The Natural History of Dermatosparaxis Ehlers Danlos Syndrome: An Adult Case Series.

C Angwin, P Byers, E Dulfer, N Ghali, Juliette Harris, I Hausser, Abigail McElroy, G Sobey, F S van Dijk
Author Information
  1. C Angwin: National Ehlers Danlos Syndrome Service London, London North West University Healthcare NHS Trust, London, UK. ORCID
  2. P Byers: Department of Laboratory Medicine and Pathology, Department of Medicine (Medical Genetics), University of Washington, Seattle, Washington, USA.
  3. E Dulfer: Department of Genetics, University Medical Center Groningen, Groningen, the Netherlands.
  4. N Ghali: National Ehlers Danlos Syndrome Service London, London North West University Healthcare NHS Trust, London, UK.
  5. Juliette Harris: National Ehlers Danlos Syndrome Service London, London North West University Healthcare NHS Trust, London, UK.
  6. I Hausser: Institute of Pathology IPH, EM-Lab, Heidelberg University Hospital, Heidelberg, Germany.
  7. Abigail McElroy: Horae Gene Therapy Center, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
  8. G Sobey: National Ehlers Danlos Syndrome Service Sheffield, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
  9. F S van Dijk: National Ehlers Danlos Syndrome Service London, London North West University Healthcare NHS Trust, London, UK. ORCID

Abstract

Dermatosparaxis Ehlers Danlos syndrome (dEDS) is a very rare monogenic EDS that occurs due to biallelic pathogenic variants in ADAMTS2. Fifteen individuals with dEDS have been reported in the literature, with the oldest being 19 years at follow-up. Given the lack of information regarding adults with dEDS, our aim was to describe adults with dEDS to inform management recommendations in adulthood. We report five individuals (2:3 male:female) with an age range of 22-42 years. Complications include extreme skin fragility resulting in iatrogenic injury, redundant skin folds often requiring surgical resection, severe complications following a gastric volvulus secondary to a diaphragmatic hernia, and multiple fractures. Discussion of management considerations includes thorough investigations of acute pain, careful consideration of skin closure techniques and manual handling, as well as monitoring for reduced bone mineral density after low-impact fracture and/or post-menopause.

Keywords

References

Ayoub, S., N. Ghali, C. Angwin, et al. 2020. “Clinical Features, Molecular Results, and Management of 12 Individuals With the Rare Arthrochalasia Ehlers‐Danlos Syndrome.” American Journal of Medical Genetics. Part A 182, no. 5: 994–1007.
Bar‐Yosef, O., S. Polak‐Charcon, C. Hoffman, Z. P. Feldman, M. Frydman, and J. Kuint. 2008. “Multiple Congenital Skull Fractures as a Presentation of Ehlers‐Danlos Syndrome Type VIIC.” American Journal of Medical Genetics. Part A 146A, no. 23: 3054–3057. https://doi.org/10.1002/ajmg.a.32541.
Bowen, J. M., G. J. Sobey, N. P. Burrows, et al. 2017. “Ehlers–Danlos Syndrome, Classical Type.” American Journal of Medical Genetics. Part C, Seminars in Medical Genetics 175, no. 1: 27–39. https://doi.org/10.1002/ajmg.c.31548.
Brady, A. F., S. Demirdas, S. Fournel‐Gigleux, et al. 2017. “The Ehlers–Danlos Syndromes, Rare Types.” American Journal of Medical Genetics. Part C, Seminars in Medical Genetics 175, no. 1: 70–115. https://doi.org/10.1002/ajmg.c.31550.
Colige, A., L. Nuytinck, I. Hausser, et al. 2004. “Novel Types of Mutation Responsible for the Dermatosparactic Type of Ehlers‐Danlos Syndrome (Type VIIC) and Common Polymorphisms in the ADAMTS2 Gene.” Journal of Investigative Dermatology 123: 656–663. https://doi.org/10.1111/j.0022‐202X.2004.23406.x.
Colige, A., A. L. Sieron, S. W. Li, et al. 1999. “Human Ehlers‐Danlos Syndrome Type VII C and Bovine Dermatosparaxis Are Caused by Mutations in the Procollagen I N‐Proteinase Gene.” American Journal of Human Genetics 65: 308–317. https://doi.org/10.1086/302504.
Dalgleish, R., and W. K. Teh. 2012. “Ehlers Danlos Syndrome Variant Database.” https://databases.lovd.nl/shared/genes/ADAMTS2.
De Coster, P. J., F. Malfait, L. C. Martens, and A. De Paepe. 2003. “Unusual Oral Findings in Dermatosparaxis (Ehlers–Danlos Syndrome Type VIIC).” Journal of Oral Pathology & Medicine 32: 568–570.
Fujimoto, A., W. R. Wilcox, and D. H. Cohn. 1997. “Clinical, Morphological, and Biochemical Phenotype of a New Case of Ehlers‐Danlos Syndrome Type VIIC.” American Journal of Medical Genetics 68: 25–28.
Harris, J., M. Bartlett, D. Baker, et al. 2023. “An Exemplary Model of Genetic Counselling for Highly Specialised Services.” Journal of Community Genetics 14: 115–119.
Malfait, F. 2018. “Vascular Aspects of the Ehlers‐Danlos Syndromes.” Matrix Biology 71–72: 380–395. https://doi.org/10.1016/j.matbio.2018.04.013.
Malfait, F., M. Castori, C. A. Francomano, et al. 2020. “The Ehlers–Danlos Syndromes.” Nature Reviews. Disease Primers 6, no. 1: 64. https://doi.org/10.1038/s41572‐020‐0194‐9.
Malfait, F., P. De Coster, I. Hausser, et al. 2004. “The Natural History, Including Orofacial Features of Three Patients With Ehlers‐Danlos Syndrome, Dermatosparaxis Type (EDS Type VIIC).” American Journal of Medical Genetics 131A: 18–28. https://doi.org/10.1002/ajmg.a.30299.
Malfait, F., C. Francomano, P. Byers, et al. 2017. “The 2017 International Classification of the Ehlers–Danlos Syndromes.” American Journal of Medical Genetics. Part C, Seminars in Medical Genetics 175, no. 1: 8–26. https://doi.org/10.1002/ajmg.c.31552.
Nusgens, B. V., C. Verellen‐Dumoulin, T. Hermanns‐Lê, et al. 1992. “Evidence for a Relationship Between Ehlers–Danlos Type VII C in Humans and Bovine Dermatosparaxis.” Nature Genetics 1: 214–217.
Pasch, M. C., J. H. Sillevis Smitt, L. Veenhuizen, G. R. Kuiters, and A. van Essen. 2000. “Boy With Dermatosparaxis (Ehlers‐Danlos Type VIIC).” Nederlands Tijdschrift voor Geneeskunde 144: 2435–2436.
Petty, E. M. 1993. “Dermatosparaxis in Children. A Case Report and Review of the Newly Recognized Phenotype.” Archives of Dermatology 129: 1310–1315.
Reardon, W., R. M. Winter, L. T. Smith, B. D. Lake, M. Rossiter, and M. Baraitser. 1995. “The Natural History of Human Dermatosparaxis (Ehlers‐Danlos Syndrome Type VIIC).” Clinical Dysmorphology 4: 1–11.
Rincón‐Sánchez, A. R., I. E. Arce, E. A. Tostado‐Rabago, et al. 2012. “Ehlers‐Danlos Syndrome Type VIIC: A Mexican Case Report.” Case Reports in Dermatology 4: 104–113.
Smith, L. T., W. Wertelecki, L. M. Milstone, et al. 1992. “Human Dermatosparaxis: A Form of Ehlers‐Danlos Syndrome That Results From Failure to Remove the Amino‐Terminal Propeptide of Type I Procollagen.” American Journal of Human Genetics 51: 235–244.
Solomons, J., P. Coucke, S. Symoens, et al. 2013. “Dermatosparaxis (Ehlers‐Danlos Type VIIC): Prenatal Diagnosis Following a Previous Pregnancy With Unexpected Skull Fractures at Delivery.” American Journal of Medical Genetics. Part A 161, no. 5: 1122–1125. https://doi.org/10.1002/ajmg.a.35802.
Steiner, R. D., and D. Basel. 2024. “COL1A1/2 Osteogenesis Imperfecta.” https://www.ncbi.nlm.nih.gov/books/NBK1295/.
Van Damme, T., A. Colige, D. Syx, et al. 2016. “Expanding the Clinical and Mutational Spectrum of the Ehlers‐Danlos Syndrome, Dermatosparaxis Type.” Genetics in Medicine 18: 882–891. https://doi.org/10.1038/gim.2015.188.
Wertelecki, W., L. T. Smith, and P. Byers. 1992. “Initial Observations of Human Dermatosparaxis: Ehlers‐Danlos Syndrome Type VIIC.” Journal of Pediatrics 121: 558–564.

MeSH Term

Humans
Ehlers-Danlos Syndrome
Male
Female
Adult
Young Adult
Skin
Mutation

Word Cloud

Similar Articles

Cited By